Anika Therapeutics, Inc., (NASDAQ: ANIK) announced the enrollment of the first patient in its pivotal HYALOFAST® FastTRACK Phase III clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE